Acquisition Alignment Thoratec is now part of St. Jude Medical and subsequently Abbott, indicating a corporate trajectory focused on expanding cardiovascular device capabilities. Sales opportunities may arise from cross-selling with St. Jude Abbott portfolios, leveraging integration projects, and targeting customers seeking broader mechanical circulatory support solutions under a unified enterprise.

Mechanical Circulatory The company provides the broadest mechanical circulatory support portfolio to treat varied clinical needs. This suggests a market opportunity to upsell or bundle complementary devices, accessories, and services to hospitals pursuing comprehensive heart failure programs and premium patient care pathways.

Mid Market Presence With 201-500 employees and revenue in the $50M-$100M range, Thoratec sits in the mid-market tier. Targeted outreach to regional cardiac centers, community hospitals expanding their advanced heart failure capabilities, and mid-sized health systems could yield strategic partnerships and faster adoption of newer technologies.

Growth through Integration Historical acquisitions and current ownership by larger corporate groups (St. Jude Medical, Abbott) signal potential for sales motions around integration projects, migration of legacy Thoratec customers to newer platforms, and opportunity to position upgrades, service contracts, and training packages aligned with enterprise-wide deployment goals.

Digital & Outreach The tech stack and online presence indicate ongoing digital marketing and analytics usage. There is room to enhance digital demand generation, thought leadership content, and patient-centered outcome storytelling to drive inquiries from cardiology and surgical teams, while aligning with enterprise channels for procurement and institutional partnerships.